These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28981554)

  • 1. Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation.
    von Ungern-Sternberg SNI; Vogel S; Walker-Allgaier B; Geue S; Maurer A; Wild AM; Münzer P; Chatterjee M; Heinzmann D; Kremmer E; Borst O; Loughran P; Zernecke A; Neal MD; Billiar TR; Gawaz M; Seizer P
    Thromb Haemost; 2017 Nov; 117(11):2063-2078. PubMed ID: 28981554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophilin A is an important mediator of platelet function by regulating integrin αIIbβ3 bidirectional signalling.
    Wang L; Soe NN; Sowden M; Xu Y; Modjeski K; Baskaran P; Kim Y; Smolock EM; Morrell CN; Berk BC
    Thromb Haemost; 2014 May; 111(5):873-82. PubMed ID: 24429998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Kv1.3 Channels in Platelet Functions and Thrombus Formation.
    Fan C; Yang X; Wang WW; Wang J; Li W; Guo M; Huang S; Wang Z; Liu K
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2360-2375. PubMed ID: 32787516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
    Heinzmann D; Bangert A; Müller AM; von Ungern-Sternberg SN; Emschermann F; Schönberger T; Chatterjee M; Mack AF; Klingel K; Kandolf R; Malesevic M; Borst O; Gawaz M; Langer HF; Katus H; Fischer G; May AE; Kaya Z; Seizer P
    PLoS One; 2015; 10(4):e0124606. PubMed ID: 25894208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophilin A is a ligand for RAGE in thrombo-inflammation.
    Seizer P; von Ungern-Sternberg SNI; Haug V; Dicenta V; Rosa A; Butt E; Nöthel M; Rohlfing AK; Sigle M; Nawroth PP; Nussbaum C; Sperandio M; Kusch C; Meub M; Sauer M; Münzer P; Bieber K; Stanger A; Mack AF; Huber R; Brand K; Lehners M; Feil R; Poso A; Krutzke K; Schäffer TE; Nieswandt B; Borst O; May AE; Zernecke A; Gawaz M; Heinzmann D
    Cardiovasc Res; 2024 Mar; 120(4):385-402. PubMed ID: 38175781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation.
    Chrysanthopoulou A; Kambas K; Stakos D; Mitroulis I; Mitsios A; Vidali V; Angelidou I; Bochenek M; Arelaki S; Arampatzioglou A; Galani IE; Skendros P; Couladouros EA; Konstantinides S; Andreakos E; Schäfer K; Ritis K
    J Pathol; 2017 Sep; 243(1):111-122. PubMed ID: 28678391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction.
    Seizer P; Fuchs C; Ungern-Sternberg SN; Heinzmann D; Langer H; Gawaz M; May AE; Geisler T
    Platelets; 2016; 27(2):155-8. PubMed ID: 26084004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions.
    Coenen DM; Heinzmann ACA; Oggero S; Albers HJ; Nagy M; Hagué P; Kuijpers MJE; Vanderwinden JM; van der Meer AD; Perretti M; Koenen RR; Cosemans JMEM
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the plasma SCUBE1, a novel platelet adhesive protein, protects mice against thrombosis.
    Wu MY; Lin YC; Liao WJ; Tu CF; Chen MH; Roffler SR; Yang RB
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1390-8. PubMed ID: 24833801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation.
    Elvers M; Herrmann A; Seizer P; Münzer P; Beck S; Schönberger T; Borst O; Martin-Romero FJ; Lang F; May AE; Gawaz M
    Blood; 2012 Aug; 120(6):1317-26. PubMed ID: 22740452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
    Chatterjee M; Behrendt A; Schmid M; Beck S; Schneider M; Mack A; Müller I; Geisler T; Gawaz M
    Thromb Haemost; 2017 Jan; 117(2):311-324. PubMed ID: 27929199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NaoXinTong Capsule Inhibits Carrageenan-Induced Thrombosis in Mice.
    Li Q; Chen Y; Zhao D; Wei Z; Zhang S; Chen Y; Wang Y; Qian K; Zhao B; Zhu Y; Gao X; Dong P; Li X; Duan Y; Han J; Yang X
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):49-59. PubMed ID: 29738376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
    Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
    Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.
    Seizer P; Ochmann C; Schönberger T; Zach S; Rose M; Borst O; Klingel K; Kandolf R; MacDonald HR; Nowak RA; Engelhardt S; Lang F; Gawaz M; May AE
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1377-86. PubMed ID: 21441138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of extracellular cyclophilin A to ACE2 and CD147 triggers psoriasis-like inflammation.
    Yang W; Bai X; Jia X; Li H; Min J; Li H; Zhang H; Zhou J; Zhao Y; Liu W; Xin H; Sun L
    J Autoimmun; 2024 Sep; 148():103293. PubMed ID: 39096717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of extracellular cyclophilin A on inflammatory response and anti-inflammatory activity of antibody against cyclophilin A].
    Li W; Liu W; Chen C; Fan W; Zhang H; Liu W; Sun L
    Sheng Wu Gong Cheng Xue Bao; 2018 Jan; 34(1):90-101. PubMed ID: 29380574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
    von Ungern-Sternberg SNI; Zernecke A; Seizer P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.